January 30, 2019
Case Management in HCV Infected PWID
Read More
January 30, 2019
Case Management in HCV Infected PWID
Read More
January 30, 2019
A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3
Read More
January 30, 2019
A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3
Read More
January 30, 2019
PROPHESYS 2: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b
Read More
January 30, 2019
VX-950-C211 – A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection
Read More
January 30, 2019
Effectiveness of Paritaprevir/Ritonavir – Ombitasvir, +/- Dasabuvir, +/- Ribavirin in Patients With Chronic Hepatitis C – An Observational Study in Belgium
Read More
January 30, 2019
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Read More
January 30, 2019
A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C
Read More
January 30, 2019
Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C
Read More
January 30, 2019
Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6
Read More
January 30, 2019
Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Read More
Load More
X